Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply

Journal article

Peer reviewed

E. Phillips, A. Hayden, S. Gutiérrez, N. Jahnke, B. Yip, V.D. Lima, R.S. Hogg, P.R. Harrigan and J.S.G. Montaner

AIDS, Vol.22(4), pp.548-549

2008

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

No abstract available

Title: Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply
Authors/Creators: E. Phillips (Author/Creator)
A. Hayden (Author/Creator)
S. Gutiérrez (Author/Creator)
N. Jahnke (Author/Creator)
B. Yip (Author/Creator)
V.D. Lima (Author/Creator)
R.S. Hogg (Author/Creator)
P.R. Harrigan (Author/Creator)
J.S.G. Montaner (Author/Creator)
Publication Details: AIDS, Vol.22(4), pp.548-549
Publisher: Lippincott Williams & Wilkins Ltd.
Identifiers: 991005544320307891
Copyright: © 2008 Lippincott Williams & Wilkins, Inc.
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Language: English
Resource Type: Journal article

This output has contributed to the advancement of the following goals:

Source: InCites

22 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.66 HIV; 1.66.1372 HIV Comorbidities
Web Of Science research areas: Immunology; Infectious Diseases; Virology
ESI research areas: Immunology